div style="text-align: justify; line-height: 11.4pt; margin-bottom: 6pt; font-family: 'Times New Roman', Times, serif;"As an actively managed exchange-traded fund (“ETF”), the Fund will not seek to replicate the performance of an index.  The Fund intends to achieve its investment objective by investing a majority of its net assets in U.S. and foreign exchange-listed healthcare technology companies in the U.S and a number of developed countries around the world.  Under normal circumstances, the Fund will invest at least 80% of the Fund’s net assets (plus borrowings for investment purposes) in U.S. and foreign exchange-listed equity securities of healthcare technology companies and American Depository Receipts (“ADRs”) on those securities. These securities may be of any market capitalization./divdiv style="text-align: justify; line-height: 11.4pt; margin-bottom: 6pt; font-family: 'Times New Roman', Times, serif;"Langar Investment Management, LLC (the “Advisor”) uses a combination of a top-down review and a bottom-up research methodology to select fundamentally strong companies that develop technology to create efficiency in healthcare by addressing key pain points for patients, providers, payors, and/or hospitals. span style="-keep: true"The Advisor defines pain /spanpoints span style="-keep: true"as /spanconsistent problems that a patient, provider and/or other healthcare stakeholder has when dealing with a product and/or service, which are unmet needs that are not adequately addressed for a company to solve in the market.  These companies are generally in one of the nine subsectors described below and may include robotic surgery companies, virtual and/or telemedicine companies, companies that develop next-generation insurance payment models, drug development companies leveraging artificial intelligence (AI), digital clinical trial companies, companies that address operational issues within a hospital, and companies that leverage large language model (LLM) AI to develop next best recommendation engines to improve/facilitate the intake, monitoring, and treatment of a patient.  Thespan style="-keep: true" Advisor’s selection/span process has four main stepsspan style="-keep: true" (as further described below)/span: 1) Langar’s HealthTech classification; 2) Langar Rating™; 3) Langar’s HealthTech Industry Risk Score; and 4) Investment Committee review./div div style="text-align: justify; line-height: 11.4pt; margin-bottom: 6pt; font-family: 'Times New Roman', Times, serif;"span style="text-decoration:underline"Langar’s HealthTech Classification/span/div div style="text-align: justify; line-height: 11.4pt; margin-bottom: 6pt; font-family: 'Times New Roman', Times, serif;"The Advisor starts by recategorizing public companies in the healthcare industry as defined by the Standard amp; Poor’s Global Industry Classification Standard (“GICS”) to determine the companies that fit into the Advisor’s definition of a HealthTech company.  The Advisor defines a “HealthTech Company” as a company that: i) develops technology to create efficiencies in healthcare by addressing key pain points of patients, providers, payors and/or hospitals; and ii) receives a majority of its revenue from HealthTech products and/or services as reported through filings with the SEC.  HealthTech companies can be grouped into nine subsectors:/div div style="text-align: justify; margin-left: 18pt; line-height: 11.4pt; margin-bottom: 6pt; font-family: 'Times New Roman', Times, serif;"Public HealthTech subsector definitions:/div div table cellpadding="0" class="DSPFListTable" id="z2169e3f75bb0479ab777e23b42b4a2de" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0px;" tr td style="width: 36pt; vertical-align: top; text-align: right;" div style="text-align: left; margin-left: 18pt; line-height: 11.4pt;"•/div /td td style="width: auto; vertical-align: top;" div style="text-align: justify; line-height: 11.4pt;"span style="font-weight: bold;"Access to Care/span – Provide care outside of a hospital setting through virtual, in-person, or a hybrid care combination./div /td /tr /table /div div table cellpadding="0" class="DSPFListTable" id="z51083f2e839c4d1fafeb8fd630b84ec5" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0px;" tr td style="width: 36pt; vertical-align: top; text-align: right;" div style="text-align: left; margin-left: 18pt; line-height: 11.4pt;"•/div /td td style="width: auto; vertical-align: top;" div style="text-align: justify; line-height: 11.4pt;"span style="font-weight: bold;"Biopharma/span – Pharmaceutical and biotechnology companies that use artificial intelligence/machine learning (“AI/ML”) technologies as an integral part of their drug design or development process./div /td /tr /table /div div table cellpadding="0" class="DSPFListTable" id="z0799d94f50b24b75b7238f96910edd63" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0px;" tr td style="width: 36pt; vertical-align: top; text-align: right;" div style="text-align: left; margin-left: 18pt; line-height: 11.4pt;"•/div /td td style="width: auto; vertical-align: top;" div style="text-align: justify; line-height: 11.4pt;"span style="font-weight: bold;"Clinical Trials/span – Enables the efficient deployment, tracking and/or completion of trials that support novel medications and/or treatments./div /td /tr /table /div div table cellpadding="0" class="DSPFListTable" id="zf122423521f2420db3e75a36c7051536" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0px;" tr td style="width: 36pt; vertical-align: top; text-align: right;" div style="text-align: left; margin-left: 18pt; line-height: 11.4pt;"•/div /td td style="width: auto; vertical-align: top;" div style="text-align: justify; line-height: 11.4pt;"span style="font-weight: bold;"Decision Support/span – Provides clinicians with patient-specific information, which is intelligently filtered or presented at appropriate times to enhance care./div /td /tr /table /div div table cellpadding="0" class="DSPFListTable" id="z78c32fbdb49c4b8685f3b88546031787" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0px;" tr td style="width: 36pt; vertical-align: top; text-align: right;" div style="text-align: left; margin-left: 18pt; line-height: 11.4pt;"•/div /td td style="width: auto; vertical-align: top;" div style="text-align: justify; line-height: 11.4pt;"span style="font-weight: bold;"Hospital Operations/span – Improves the efficiency of hospital workflows that are required to provide care./div /td /tr /table /div div table cellpadding="0" class="DSPFListTable" id="zd50e9b5f8aaf4306b8b83e7459c45f4c" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0px;" tr td style="width: 36pt; vertical-align: top; text-align: right;" div style="text-align: left; margin-left: 18pt; line-height: 11.4pt;"•/div /td td style="width: auto; vertical-align: top;" div style="text-align: justify; line-height: 11.4pt;"span style="font-weight: bold;"Insurance/span – Leverage AI/ML models to save costs and improve services of private and/or government programs./div /td /tr /table /div div table cellpadding="0" class="DSPFListTable" id="zbc0128b6562b40e1b0afdbe61ab2abe3" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000; border-spacing: 0px;" tr td style="width: 36pt; vertical-align: top; text-align: right;" div style="text-align: left; margin-left: 18pt; line-height: 11.4pt; margin-bottom: 6pt;"•/div /td td style="width: auto; vertical-align: top;" div style="text-align: justify; line-height: 11.4pt; margin-bottom: 6pt;"span style="font-weight: bold;"Treatment Device/span – Devices that leverage an AI/ML algorithm to facilitate treatment of a specific medical problem./div /td /tr /table /divdiv style="line-height: 11.4pt;"span style="line-height: 11.4pt; display: block;"br//span /div div style="line-height: 11.4pt; font-family: 'Times New Roman', Times, serif;"Private HealthTech subsector definitions:/div div table cellpadding="0" class="DSPFListTable" id="z71116d6de5134045b9c1b522573083eb" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0px;" tr td style="width: 36pt; vertical-align: top; text-align: right;" div style="text-align: left; margin-left: 18pt; line-height: 11.4pt;"•/div /td td style="width: auto; vertical-align: top;" div style="text-align: justify; line-height: 11.4pt;"span style="font-weight: bold;"Lifestyle Wellness/span – Assists users in navigating their overall health and wellness journey  using monitoring, counseling, education, and lifestyle changes that help prevent, treat, and provide care./div /td /tr /table /divtable cellpadding="0" class="DSPFListTable" id="z063cddd342524ed696ce48845c44f094" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000; border-spacing: 0px;" tr td style="width: 36pt; vertical-align: top; text-align: right;" div style="text-align: left; margin-left: 18pt; line-height: 11.4pt; margin-bottom: 6pt;"•/div /td td style="width: auto; vertical-align: top;" div style="text-align: justify; line-height: 11.4pt; margin-bottom: 6pt;"span style="font-weight: bold;"Prescription Management/span – Ensures a patient is properly educated, has access to and complies with prescribed usage of a medication./div /td /tr /tablediv style="line-height: 11.4pt; font-family: 'Times New Roman', Times, serif;"span style="text-decoration:underline"Langar Rating/span™/div div style="text-align: justify; line-height: 11.4pt; margin-bottom: 6pt; font-family: 'Times New Roman', Times, serif;"Companies that meet the Advisor’s definition of a HealthTech Company are then screened using the Langar Rating™.  The Langar Rating™ is a proprietary metric developed by Langar Holdings, Inc. that helps assess a company’s fundamentals relative to its peers by reviewing press releases, publicly available filings, and third-party data analysis.  The metric includes an active assessment of the qualitative and quantitative strength of the company’s business fundamentals through a review of the company’s financial health, any relevant company controversies, whether the company’s products and/or services are involved in any vice areas, as defined by the Advisor (adult entertainment, alcoholic beverages, oil and gas exploration, cannabis, weapons/small arms, fur and specialty leathers, gambling, predatory lending, riot control, tobacco products and whale meat), and the strength of the company’s team (i.e., board of directors and management team) and culture (shared values, attitudes, behaviors, and standards that make up a company’s work environment as it relates to a company’s investment potential) (derived from a subset of Refinitiv’s Environmental, Social, and Governance database).  The purpose of the vice screen is to help identify and remove from the potential universe any companies that have and/or could have performance challenges as a result of controversies and adverse public sentiment regarding their products and/or services or overall company reputation./div div style="text-align: justify; line-height: 11.4pt; margin-bottom: 6pt; font-family: 'Times New Roman', Times, serif;"span style="text-decoration:underline"Langar’s HealthTech Industry Risk Score/span/div div style="text-align: justify; line-height: 11.4pt; margin-bottom: 6pt; font-family: 'Times New Roman', Times, serif;"The Advisor then applies the Langar Industry Risk Score™ to assign an industry risk score to each company.  The proprietary algorithm evaluates the healthcare industry risk of the company by defining a quantitative risk and qualitative risk category for each company and weights the company accordingly.  The quantitative risk category includes revenue risk (which is defined as which customer segment contributes to a majority of the company’s revenue) and innovation risk (which evaluates how well a company has protected its intellectual property and whether they are able to generate a gross profit).  The qualitative risk category includes standard of care risk (which analyzes whether a company’s product and/or service has aligned with current clinical practices), and policy risk (which determines if the company’s product and/or service is subject to state and/or federal policy shifts).  The Advisor applies weighting to the portfolio based on the market cap and revenue growth to place more weight on high growth potential companies./div div style="text-align: justify; line-height: 11.4pt; margin-bottom: 6pt; font-family: 'Times New Roman', Times, serif;"span style="text-decoration:underline"Investment Committee Review/span/div div style="text-align: justify; line-height: 11.4pt; margin-bottom: 6pt; font-family: 'Times New Roman', Times, serif;"Finally, each company is then reviewed by the Advisor’s Investment Committee, which includes a seasoned team of healthcare and financial subject matter experts and provides input on the companies presented before the portfolio manager selects the companies span style="-keep: true"to be/span included in the Fund’s portfolio. However, the span style="-keep: true"Fund’s /spanportfolio manager has complete discretion over the companies ultimately selected for inclusion in the Fund’s portfolio./div div style="text-align: justify; line-height: 11.4pt; margin-bottom: 6pt; font-family: 'Times New Roman', Times, serif;"On at least a quarterly basis, the Advisor may rebalance the portfolio to add new securities that meet the criteria discussed above, change the weighting of securities or remove securities that no longer meet the criteria discussed above.  The Advisor may sell securities at any time if the Advisor believes that the company has made a business decision that will negatively impact its long-term growth./divdiv style="text-align: justify; line-height: 11.4pt; margin-bottom: 6pt; font-family: 'Times New Roman', Times, serif;"The Fund is classified as “non-diversified” for purposes of the Investment Company Act of 1940, as amended (the “1940 Act”), which means a relatively high percentage of the Fund’s assets may be invested in the securities of a limited number of issuers. The Fund will also be concentrated (invest at least 25% of the Fund’s assets) in companies in healthcare industry as defined by GICS./div div style="text-align: justify; line-height: 11.4pt; margin-bottom: 6pt; font-family: 'Times New Roman', Times, serif;"span style="-keep: true"As an actively managed ETF that does not seek to replicate the performance of a specified index, the Fund may have a higher degree of portfolio turnover than funds that seek to replicate the performance of an index./span/div div style="text-align: justify; line-height: 11.4pt; margin-bottom: 6pt; font-family: 'Times New Roman', Times, serif;"span style="-keep: true"From time to time the Fund may focus its investments in one or more particular sectors. As of December 31, 2025, the Fund focused its investments in the medical equipment sector./span/div